Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for intensive chemotherapy: a propensity score-matched study - Takeaways - MDSpire

Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for intensive chemotherapy: a propensity score-matched study

  • By

  • Bingqian Huang

  • Yawen Wang

  • Yubin Li

  • Jiahui Mao

  • Ruixue Wang

  • Gaoyu Lv

  • Ming Hou

  • Yan Shi

  • June 18, 2026

  • 0 min

Share

  • 1

    Immunotherapy with Blinatumomab or Inotuzumab Ozogamicin shows higher MRD negativity rates compared to standard chemotherapy in newly diagnosed B-ALL patients.

  • 2

    The study involved 133 patients, with 25 receiving immunotherapy and 108 receiving standard chemotherapy, matched for various clinical factors.

  • 3

    Patients in the immunotherapy group had significantly higher median neutrophil and platelet counts, indicating better hematologic recovery.

  • 4

    Fewer pulmonary infections and transfusions were observed in the immunotherapy group, suggesting improved safety and tolerability.

  • 5

    The findings support the potential of immunotherapy as a first-line treatment option for fit patients with newly diagnosed B-ALL.

Original Source(s)

Immunotherapy with or without low-intensity chemotherapy versus conventional chemotherapy as first-line treatment for newly diagnosed B-ALL patients fit for intensive chemotherapy: a propensity score-matched study

  • by Bingqian Huang, Yawen Wang, Yubin Li, Jiahui Mao, Ruixue Wang, Gaoyu Lv, Ming Hou, Yan Shi

  • June 18, 2026

Related Content

Temporal dynamics and determinants of early recurrence after curative resection for stage I-III rectal cancer: integrated analyses of hazard function, survival, and competing risks

Comparative study of triple intravenous chemotherapy versus dual chemotherapy combined with hepatic arterial infusion in patients with liver metastases from colorectal cancer

Active surveillance or surgical resection? A survey of treatment strategies for low-risk papillary thyroid microcarcinoma in adults